A detailed history of Smartleaf Asset Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 1,039 shares of MRNA stock, worth $45,082. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,039
Previous 579 79.45%
Holding current value
$45,082
Previous $70.2 Million 2.64%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $29,274 - $57,564
460 Added 79.45%
1,039 $68.3 Million
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $3,441 - $5,664
-34 Reduced 5.55%
579 $70.2 Million
Q1 2024

Oct 07, 2024

BUY
$85.37 - $115.44 $2,902 - $3,924
34 Added 5.87%
613 $67.8 Million
Q1 2024

May 02, 2024

BUY
$85.37 - $115.44 $47,807 - $64,646
560 Added 1056.6%
613 $44.4 Million
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $3,684 - $5,534
53 New
53 $5.23 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $17B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.